140 related articles for article (PubMed ID: 12405266)
41. Expression of anti-tumor necrosis factor alpha (TNFα) single-chain variable fragment (scFv) in Spirodela punctata plants transformed with Agrobacterium tumefaciens.
Balaji P; Satheeshkumar PK; Venkataraman K; Vijayalakshmi MA
Biotechnol Appl Biochem; 2016 May; 63(3):354-61. PubMed ID: 25786575
[TBL] [Abstract][Full Text] [Related]
42. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
[TBL] [Abstract][Full Text] [Related]
43. Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery.
Fisher AC; DeLisa MP
J Mol Biol; 2009 Jan; 385(1):299-311. PubMed ID: 18992254
[TBL] [Abstract][Full Text] [Related]
44. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
45. A genetically engineered single-gene-encoded anti-TAG72 chimeric antibody secreted from myeloma cells.
Qi Y; Xiang J
Hum Antibodies Hybridomas; 1995; 6(4):161-6. PubMed ID: 8688499
[TBL] [Abstract][Full Text] [Related]
46. [Cloning and expression of human single-chain Fv antibody against A beta(1-42) peptide involved in Alzheimer disease].
Jia J; Liu Z; Zhao XM; Liang P
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):400-4. PubMed ID: 19031720
[TBL] [Abstract][Full Text] [Related]
47. A role for intracellular immunization in chemosensitization of tumor cells?
Pich A; Rancourt C
Gene Ther; 1999 Jul; 6(7):1202-9. PubMed ID: 10455428
[TBL] [Abstract][Full Text] [Related]
48. Effects of genetic engineering on the pharmacokinetics of antibodies.
Colcher D; Goel A; Pavlinkova G; Beresford G; Booth B; Batra SK
Q J Nucl Med; 1999 Jun; 43(2):132-9. PubMed ID: 10429508
[TBL] [Abstract][Full Text] [Related]
49. Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors.
Beckman RA; Weiner LM; Davis HM
Cancer; 2007 Jan; 109(2):170-9. PubMed ID: 17154393
[TBL] [Abstract][Full Text] [Related]
50. Generation of functional scFv intrabodies for triggering anti-tumor immunity.
Bonnin E; Gruel N; Moutel S; Mantegazza AR; Barrio MM; Mordoh J; Teillaud JL
Methods; 2004 Oct; 34(2):225-32. PubMed ID: 15312675
[TBL] [Abstract][Full Text] [Related]
51. Antisense oligonucleotides and prevention of tumor growth: a different approach and proposal for a new method.
Yildiz D; Oztas H; Hilal Ates B
Med Hypotheses; 2005; 64(2):328-32. PubMed ID: 15607566
[TBL] [Abstract][Full Text] [Related]
52. Efficient production of single-chain Fv antibody possessing rare codon linkers in fed-batch fermentation.
Kumada Y; Sakan Y; Kajihara H; Kihara M; Kikuchi Y; Yamaji H; Seong GH; Katoh S
J Biosci Bioeng; 2009 Jan; 107(1):73-7. PubMed ID: 19147114
[TBL] [Abstract][Full Text] [Related]
53. Antigen-independent selection of intracellular stable antibody frameworks.
Auf der Maur A; Tissot K; Barberis A
Methods; 2004 Oct; 34(2):215-24. PubMed ID: 15312674
[TBL] [Abstract][Full Text] [Related]
54. Targeting dsRNA-specific single-chain Fv antibody fragments to different cellular locations in Nicotiana tabacum L.
Morgun B; Richter A; Deshmukh SD; Stepanyuk V; Kálai K; Nagy G; Hufnagel L; Lukács N
Acta Biol Hung; 2006 Jun; 57(2):247-59. PubMed ID: 16841475
[TBL] [Abstract][Full Text] [Related]
55. [Research progress in gene engineered antibodies].
Xiong SD; Wen BG; Li GW
Sheng Li Ke Xue Jin Zhan; 2001 Jan; 32(1):23-6. PubMed ID: 12545772
[TBL] [Abstract][Full Text] [Related]
56. Engineered antibodies take center stage.
Huston JS; George AJ
Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
[TBL] [Abstract][Full Text] [Related]
57. Single-chain antibody-delivered Livin siRNA inhibits human malignant melanoma growth in vitro and in vivo.
Wang H; Yang Y; Wang W; Guan B; Xun M; Zhang H; Wang Z; Zhao Y
Tumour Biol; 2017 May; 39(5):1010428317701645. PubMed ID: 28459204
[TBL] [Abstract][Full Text] [Related]
58. Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis.
Conrad C; Hüsemann Y; Niess H; von Luettichau I; Huss R; Bauer C; Jauch KW; Klein CA; Bruns C; Nelson PJ
Ann Surg; 2011 Mar; 253(3):566-71. PubMed ID: 21169810
[TBL] [Abstract][Full Text] [Related]
59. Design and function of triplex hairpin ribozymes.
Aquino-Jarquin G; Rojas-Hernández R; Alvarez-Salas LM
Methods Mol Biol; 2010; 629():323-38. PubMed ID: 20387159
[TBL] [Abstract][Full Text] [Related]
60. [Therapeutic approaches using genetically modified cells].
Anliker B; Renner M; Schweizer M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1274-80. PubMed ID: 26349563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
